{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:02:08Z","timestamp":1794085328128,"version":"4.8.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.exphem.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T04:21:14Z","timestamp":1434774074000},"page":"640-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"43","author":[{"given":"Farzaneh","family":"Ghazavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Van Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Poppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Speleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Moerloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.05.015_bib1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.015_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.05.015_bib3","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1172\/JCI61203","article-title":"Molecular genetics of B-precursor acute lymphoblastic leukemia","volume":"122","author":"Mullighan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.05.015_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1468-0734.2002.00069.x","article-title":"Cytogenetics and molecular genetics of acute lymphoblastic leukemia","volume":"6","author":"Harrison","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: Insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2404691","article-title":"High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression","volume":"21","author":"Kuiper","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib7","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib8","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1182\/blood-2006-05-025221","article-title":"A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5","volume":"109","author":"Bousquet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib9","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1182\/blood-2015-02-626127","article-title":"Pax5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia","volume":"125","author":"Dang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.05.015_bib11","doi-asserted-by":"crossref","first-page":"17905","DOI":"10.1074\/jbc.M400589200","article-title":"Pearson correlation analysis of microarray data allows for the identification of genetic targets for early B-cell factor","volume":"279","author":"M\u00e5nsson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.015_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.immuni.2007.05.010","article-title":"The transcriptional regulation of B cell lineage commitment","volume":"26","author":"Nutt","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2015.05.015_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20101947","article-title":"Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia","volume":"208","author":"Heltemes-Harris","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.015_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.015_bib15","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","article-title":"Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A children's oncology group study","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3324\/haematol.2011.056135","article-title":"IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol","volume":"98","author":"Dorge","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib17","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.3324\/haematol.2013.099077","volume":"98","author":"Palmi","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.015_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","article-title":"A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups","volume":"113","author":"Sulong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib20","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/sj.onc.1205322","article-title":"Tumor suppressor genes in normal and malignant hematopoiesis","volume":"21","author":"Krug","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.015_bib21","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/hmg\/ddq224","article-title":"The correlation pattern of acquired copy number changes in 164 ETV6\/RUNX1-positive childhood acute lymphoblastic leukemias","volume":"19","author":"Lilljebj\u00f6rn","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1074\/jbc.275.1.147","article-title":"The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation","volume":"275","author":"Prevot","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.015_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.4049\/jimmunol.182.3.1509","article-title":"B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK","volume":"182","author":"Vendel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2015.05.015_bib24","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.4049\/jimmunol.173.11.6786","article-title":"Molecular mechanisms of CD200 inhibition of mast cell activation","volume":"173","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2015.05.015_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2008-08-170928","article-title":"Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia","volume":"113","author":"Kearney","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function","volume":"206","author":"Trageser","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.015_bib27","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/leu.2010.87","article-title":"IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL","volume":"24","author":"Kuiper","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib28","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2009-10-251413","article-title":"Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia","volume":"115","author":"Bateman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib29","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2015.126953","article-title":"CD200\/BTLA deletions in pediatric precursor-B cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol","author":"Ghazavi","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1006\/bbrc.1999.1605","article-title":"The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A","volume":"264","author":"Chakrabarti","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2015.05.015_bib31","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1038\/sj.onc.1203899","article-title":"Tel induces a G1 arrest and suppresses Ras-induced transformation","volume":"19","author":"Rompaey","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.015_bib32","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.leu.2400785","article-title":"Chromosome abnormalities of the short arm of chromosome 12 in hematopoietic malignancies: A report including three novel translocations involving the TEL\/ETV6 gene","volume":"11","author":"Berger","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood.V91.4.1399","article-title":"Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies","volume":"91","author":"Wlodarska","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1098-2264(199803)21:3<223::AID-GCC6>3.0.CO;2-1","article-title":"Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies","volume":"21","author":"Tosi","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib35","first-page":"59","article-title":"The role of chromosome translocations in leukemogenesis","volume":"36","author":"Rowley","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/gcc.1127","article-title":"Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and\u00a0spectral karyotyping","volume":"31","author":"Odero","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib37","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood.V87.7.2891.bloodjournal8772891","article-title":"The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia","volume":"87","author":"Raynaud","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib38","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1038\/sj.onc.1208588","article-title":"Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia","volume":"24","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.015_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/gcc.20147","article-title":"Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation","volume":"42","author":"Hosoya","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib40","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2400798","article-title":"ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia","volume":"11","author":"Cav\u00e9","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4614-6176-0_15","article-title":"Genetic targets in pediatric acute lymphoblastic leukemia","volume":"779","author":"Gowda","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.exphem.2015.05.015_bib42","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2003-07-2441","article-title":"FLT3 mutations in\u00a0childhood acute lymphoblastic leukemia","volume":"103","author":"Armstrong","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2003-02-0418","article-title":"FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy","volume":"103","author":"Taketani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib44","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3109\/10428194.2013.847934","article-title":"Impact of mutations in FLT3, PTPN11 and RAS genes on the overall survival of pediatric B cell precursor acute lymphoblastic leukemia in Brazil","volume":"55","author":"Barbosa","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2015.05.015_bib45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/gcc.20671","article-title":"High hyperdiploid childhood acute lymphoblastic leukemia","volume":"48","author":"Paulsson","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib46","doi-asserted-by":"crossref","first-page":"21719","DOI":"10.1073\/pnas.1006981107","article-title":"Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"107","author":"Paulsson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.015_bib47","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1182\/blood-2012-06-437681","article-title":"Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results","volume":"121","author":"Dastugue","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib48","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3324\/haematol.2013.085852","article-title":"High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992\/2000 protocols","volume":"98","author":"Paulsson","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib49","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood-2003-04-1128","article-title":"Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia","volume":"102","author":"Moorman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x","article-title":"Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party","volume":"96","author":"Secker-Walker","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib51","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique","volume":"88","author":"Charrin","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib52","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood.V79.12.3316.bloodjournal79123316","article-title":"Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study","volume":"79","author":"Harris","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib53","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/1097-0142(19900915)66:6<1183::AID-CNCR2820660618>3.0.CO;2-P","article-title":"Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6: A pediatric oncology group study","volume":"66","author":"Jackson","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib54","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2000.18.9.1876","article-title":"Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes)","volume":"18","author":"Heerema","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib55","first-page":"222","article-title":"Isochromosome 17q in childhood acute lymphoblastic leukemia: An adverse cytogenetic feature in association with hyperdiploidy","volume":"2","author":"Pui","year":"1988","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/gcc.20502","article-title":"Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia","volume":"47","author":"Paulsson","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib57","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/leu.2010.39","article-title":"Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: Presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations","volume":"24","author":"Davidsson","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib58","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/leu.2012.60","article-title":"CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"26","author":"Inthal","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia","volume":"125","author":"Harrison","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib61","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood.V86.11.4263.bloodjournal86114263","article-title":"High-frequency of T(12-21) in childhood B-lineage acute lymphoblastic leukemia","volume":"86","author":"Romana","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-4608(96)00418-9","article-title":"Low frequency of TEL\/AML1 in adult acute lymphoblastic leukemia","volume":"98","author":"Kwong","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2015.05.015_bib63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.leu.2402435","article-title":"ETV6\/AML1 fusion by FISH in adult acute lymphoblastic leukemia","volume":"16","author":"Jabber Al-Obaidi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/gcc.2870090307","article-title":"t(12;21): A new recurrent translocation in acute lymphoblastic leukemia","volume":"9","author":"Romana","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib65","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252","article-title":"TEL\/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia","volume":"88","author":"McLean","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib66","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V90.2.571","volume":"90","author":"Borkhardt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib67","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/bcj.2013.48","article-title":"The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods","volume":"3","author":"Linka","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2015.05.015_bib68","doi-asserted-by":"crossref","first-page":"e26348","DOI":"10.1371\/journal.pone.0026348","article-title":"The leukemia-specific fusion gene ETV6\/RUNX1 perturbs distinct key biological functions primarily by gene repression","volume":"6","author":"Fuka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2015.05.015_bib69","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/leu.2011.322","article-title":"Silencing of ETV6\/RUNX1 abrogates PI3K\/AKT\/mTOR signaling and impairs reconstitution of leukemia in xenografts","volume":"26","author":"Fuka","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2004.07.169","article-title":"TEL\/AML1 shows dominant-negative effects over TEL as well as AML1","volume":"322","author":"Gunji","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2015.05.015_bib71","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1128\/MCB.16.4.1349","article-title":"The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription","volume":"16","author":"Hiebert","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.015_bib72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2010-09-309070","article-title":"ETV6\/RUNX1 (TEL\/AML1) is a frequent prenatal first hit in childhood leukemia","volume":"117","author":"Zuna","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib73","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2003-10-3695","article-title":"TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity","volume":"103","author":"Morrow","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib74","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","article-title":"Prenatal origin of acute lymphoblastic leukaemia in children","volume":"354","author":"Wiemels","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2015.05.015_bib75","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib76","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1182\/blood-2011-02-338848","article-title":"Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice","volume":"118","author":"Van der Weyden","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib77","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/gcc.20613","article-title":"The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1","volume":"47","author":"Parker","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib78","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1990.8.8.1380","article-title":"Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the T(1\u201319)","volume":"8","author":"Raimondi","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib79","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1200\/JCO.1994.12.12.2601","article-title":"Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative","volume":"12","author":"Pui","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib80","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1998.16.2.527","article-title":"Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: A report from the Children's Cancer Group","volume":"16","author":"Uckun","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib81","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/leu.2009.251","article-title":"Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia","volume":"24","author":"Schmiegelow","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib82","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1038\/sj.onc.1204592","article-title":"The role of E2A-PBX1 in leukemogenesis","volume":"20","author":"Aspland","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.015_bib83","doi-asserted-by":"crossref","first-page":"e87602","DOI":"10.1371\/journal.pone.0087602","article-title":"Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein","volume":"9","author":"Diakos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2015.05.015_bib84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2011.08824.x","article-title":"Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): Clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols","volume":"155","author":"Andersen","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib85","first-page":"363","article-title":"Prognostic significance of the balanced T(1,19) and unbalanced Der(19)T(1,19) translocations in acute lymphoblastic leukemia","volume":"6","author":"SeckerWalker","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0140-6736(91)90733-6","article-title":"Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy","volume":"337","author":"Rivera","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2015.05.015_bib87","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3324\/haematol.11239","article-title":"Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children","volume":"92","author":"Kager","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/leu.2009.252","article-title":"Long-term results of St. Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia","volume":"24","author":"Pui","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib89","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.1386162","article-title":"Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia","volume":"257","author":"Inaba","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.015_bib90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/leu.2010.253","article-title":"The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors","volume":"25","author":"De Boer","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib91","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/pbc.23383","article-title":"In\u00a0vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia","volume":"59","author":"Glover","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib92","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V70.4.948.948","article-title":"Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia","volume":"70","author":"Ribeiro","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib93","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.3541203","article-title":"Unique forms of the Abl tyrosine kinase distinguish Ph1-positive Cml from Ph1-positive All","volume":"235","author":"Clark","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.015_bib95","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0950-3536(87)80035-5","article-title":"The BCR\/ABL hybrid gene","volume":"1","author":"Groffen","year":"1987","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib96","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of Bcr-Abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.015_bib97","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: A children's oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib98","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/cncr.28598","article-title":"Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"120","author":"Jeha","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"Roberts","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.015_bib100","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report","volume":"27","author":"Martinelli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib101","doi-asserted-by":"crossref","first-page":"10735","DOI":"10.1073\/pnas.88.23.10735","article-title":"Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias","volume":"88","author":"Ziemin-van der Poel","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.015_bib102","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2402468","article-title":"Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: Report from the MRC Childhood Leukaemia working party","volume":"16","author":"Chessells","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib103","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V81.9.2386.2386","article-title":"Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome","volume":"81","author":"Chen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib104","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2141.1997.3493163.x","article-title":"Cytogenetics and prognosis in childhood lymphoblastic leukaemia: Results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia","volume":"99","author":"Chessels","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib105","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib106","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.hoc.2009.07.001","article-title":"Cytogenetics and molecular genetics of acute lymphoblastic leukemia","volume":"23","author":"Mr\u00f3zek","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2015.05.015_bib107","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2010-03-273532","article-title":"Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: Results from the Interfant-99 Study","volume":"116","author":"Mann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib108","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib109","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.leu.2404578","article-title":"Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement","volume":"21","author":"Jansen","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.015_bib111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.015_bib112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.015_bib113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOH.0000000000000123","article-title":"Mixed lineage rearranged leukaemia: Pathogenesis and targeting DOT1L","volume":"22","author":"Stein","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib114","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib115","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/gcc.22090","article-title":"The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia","volume":"52","author":"Dobbins","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib116","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2407-13-55","article-title":"Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia","volume":"13","author":"Chang","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib117","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3960\/jslrt.50.91","article-title":"11q23\/MLL acute leukemia: Update of clinical aspects","volume":"50","author":"Tamai","year":"2010","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.exphem.2015.05.015_bib119","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2009-07-233049","article-title":"Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants","volume":"115","author":"Stam","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1535-6108(03)00003-5","article-title":"Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification","volume":"3","author":"Armstrong","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.015_bib121","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.seminhematol.2013.10.001","article-title":"Genomic characterization of childhood acute lymphoblastic leukemia","volume":"50","author":"Mullighan","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: A genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib123","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib124","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib125","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib126","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.05.015_bib127","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","article-title":"Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia","volume":"31","author":"Weston","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib128","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.3324\/haematol.2013.095372","article-title":"Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion","volume":"98","author":"Lengline","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12185-011-0910-z","article-title":"RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations","volume":"94","author":"Inokuchi","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.leu.2402849","article-title":"Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: A study of 20 cases","volume":"17","author":"Harewood","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib131","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): Cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib132","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2014-08-569228","article-title":"Blood spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease","volume":"125","author":"Harrison","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib133","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood-2006-08-040436","article-title":"Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib134","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9377","article-title":"Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: A comparison of the MRC ALL97\/99 and UKALL2003 trials","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib135","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1182\/blood-2011-01-329961","article-title":"Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia","volume":"117","author":"Rand","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib136","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.015_bib137","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2009-09-235986","article-title":"Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: Rare clinical curios or potent genetic drivers?","volume":"115","author":"Dyer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib138","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood-2007-07-092015","article-title":"t(6;14)(p22;q32): A new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"111","author":"Russell","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib139","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/leu.2008.250","article-title":"A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin","volume":"23","author":"Russell","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/modpathol.2013.149","article-title":"B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH\/EPOR: A clinically aggressive subset of disease","volume":"27","author":"Jaso","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.exphem.2015.05.015_bib141","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood-2006-03-010835","article-title":"Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia","volume":"108","author":"Chapiro","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib142","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"109","author":"Akasaka","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib143","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cancergen.2013.04.004","article-title":"Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature","volume":"206","author":"Chapiro","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib144","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.015_bib145","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib146","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccr.2012.07.012","article-title":"Genomic analysis drives tailored therapy in poor risk childhood leukemia","volume":"22","author":"Harrison","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.015_bib147","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/leu.2013.277","article-title":"An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions","volume":"28","author":"Clappier","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib148","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/leu.2013.282","article-title":"ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia","volume":"28","author":"Zaliova","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib149","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2008.09.005","article-title":"Global genomic characterization of acute lymphoblastic leukemia","volume":"46","author":"Mullighan","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib150","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib151","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1158\/0008-5472.CAN-11-1874","article-title":"The Pax-5 gene: A pluripotent regulator of B-cell differentiation and cancer disease","volume":"71","author":"O'Brien","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.015_bib152","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1073\/pnas.0803494105","article-title":"Variable breakpoints target PAX5 in patients with dicentric chromosomes: A model for the basis of unbalanced translocations in cancer","volume":"105","author":"An","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.015_bib153","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cancergen.2011.07.006","article-title":"FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia","volume":"204","author":"Put","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib154","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1016\/j.leukres.2012.04.015","article-title":"PAX5-AUTS2: A recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Denk","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2015.05.015_bib155","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3324\/haematol.2014.112193","article-title":"Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia","volume":"100","author":"Fazio","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.015_bib156","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/leu.2013.363","article-title":"Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A","volume":"28","author":"Auer","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.015_bib157","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.015_bib158","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/gcc.20517","article-title":"Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: A Nordic series of 24 cases and review of the literature","volume":"47","author":"Forestier","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.015_bib159","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MOH.0b013e3283034697","article-title":"Progress in the treatment of adults with acute lymphoblastic leukemia","volume":"15","author":"Larson","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2015.05.015_bib161","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Results from the UK Medical Research\u00a0Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib162","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2012.01.001","article-title":"The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia","volume":"26","author":"Moorman","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2015.05.015_bib163","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.015_bib164","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature09883","article-title":"BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition","volume":"473","author":"Duy","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.015_bib165","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.015_bib166","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","article-title":"Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia","volume":"6","author":"Ma","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2015.05.015_bib167","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.015_bib168","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1500209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1500209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:08:02Z","timestamp":1654924082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1500209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":168,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0301472X1500209X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.015","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}